1 unknown. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Unknown 1 |
Follow Dr Christophe LENCLUD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Curosurf® in Adult Acute Respiratory Distress Syndrome Due to COVID-19 poractant alfa - COVID-19, ARDS, Human | Phase 2 | Unknown | Dr Christophe LENCLUD | 20 | 2020-05-29 | 2021-02-03 |
COVID-19 (1) · Respiratory Distress Syndrome (1)
poractant alfa (1)
France (1)